Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
Crossref DOI link: https://doi.org/10.1186/s12890-017-0519-y
Published Online: 2017-12-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nitawaki, Tatsuya http://orcid.org/0000-0001-9376-1164
Sakata, Yoshihiko
Kawamura, Kodai
Ichikado, Kazuya